Talis Biomedical Corporation (TLIS)
OTCMKTS
· Delayed Price · Currency is USD
1.700
0.00 (0.00%)
Dec 27, 2024, 9:50 AM EST
Talis Biomedical Market Cap
Talis Biomedical has a market cap or net worth of $3.10 million as of December 27, 2024. Its market cap has decreased by -77.76% in one year.
Market Cap
3.10M
Enterprise Value
-37.97M
Revenue
408.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.70
Market Cap Chart
Since February 12, 2021, Talis Biomedical's market cap has decreased from 652.79M to 3.10M, a decrease of -99.53%. That is a compound annual growth rate of -74.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2024 | 3.10M | -77.16% |
| Dec 29, 2023 | 13.57M | 13.66% |
| Dec 30, 2022 | 11.94M | -88.68% |
| Dec 31, 2021 | 105.42M | -83.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 18.07B |
| Telix Pharmaceuticals Limited | 5.22B |
| Elekta AB (publ) | 2.09B |
| Ryman Healthcare Limited | 1.72B |
| Verano Holdings Corp. | 463.76M |
| Vireo Growth Inc. | 129.65M |
| Medexus Pharmaceuticals Inc. | 55.68M |